Titlebook: ;

只看該作者 · 發(fā)表于 2025-3-30 10:28:23

Novel Antibiotics in Urologye last 10?years are considered including one new siderophore cephalosporin, two new carbapenems, three cephalosporin/beta-lactamase inhibitor and two carbapenem/beta-lactamase inhibitor combinations, one novel aminoglycoside, two new fluoroquinolones, a new tetracycline, and the revival of the parenteral fosfomycin disodium.

只看該作者 · 發(fā)表于 2025-3-30 12:39:09

只看該作者 · 發(fā)表于 2025-3-30 17:16:56

只看該作者 · 發(fā)表于 2025-3-31 00:43:58

只看該作者 · 發(fā)表于 2025-3-31 04:09:05

只看該作者 · 發(fā)表于 2025-3-31 06:26:02

The Treatment of Urinary Tract Infections Caused by ESBL-Producing Gram-Negative Bacteria, Vancomyciatients with urinary tract infections (UTI) caused by ESBL, VRE, and MDR bacteria..This chapter aims to comprehensively discuss current antibacterial treatment options for uncomplicated and complicated UTI caused by multiresistant microorganisms and to provide an overview of currently available as well as upcoming therapeutic options.

只看該作者 · 發(fā)表于 2025-3-31 10:28:27

Bacteriophage Therapy for Urinary Tract Infections., we delve into the specific clinical applications of phages for treating urinary tract infections (UTIs) in patients and provide our perspective on the future of phage therapy in combating urological infections.

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 06:01
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved